REGULATORY
Japan Doles Out Orphan Tags for Nihon Servier’s Vorasidenib, 11 More APIs
Japan’s Ministry of Health, Labor and Welfare (MHLW) on December 25 designated 12 APIs as orphan drugs including Nihon Servier’s recently filed glioma treatment vorasidenib as well as other medicines by Bristol Myers Squibb and Boehringer Ingelheim. Vorasidenib was granted…
To read the full story
REGULATORY
- LDP Tax Panel OKs New 40% R&D Credit for Strategic Technologies
December 12, 2025
- Pharma Renews Call to Scrap “Spillover,” “Huge-Seller” Rules as FY2026 Talks Enter Final Stretch
December 11, 2025
- 2024 Reform Spurred New Development Activity, 20 Projects Entered Clinic: Industry Poll
December 11, 2025
- Regenerative Medicine Group Accepts Deferred Debate on Market Expansion Re-Pricing
December 11, 2025
- Wholesalers Urge Price Hikes on Sub-20-Yen Drugs as Negative Margins Mount
December 11, 2025
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…





